CD274 and neoplasm: Additionally, the list of potential predictors includes evaluation of tumor mutational burden (TMB) [16], combined assessment of PD-L1 expression and presence of tumor-infiltrating lymphocytes (TIL) [17], transcriptome analysis for detection of “inflammatory” genetic signatures [18], and the assessment of neoantigen load and immunogenicity [19,20].